Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04937400 · ClinicalTrials.gov registry record
Delirium in Children Undergoing Stem Cell Transplantation
A clinical trial of Delirium and Stem Cell Transplant Complications, sponsored by Weill Medical College of Cornell University.
- Active
- Registry status
- 1,040
- Enrollment target
- 6
- Study locations
NCT04937400: Active study of Delirium and Stem Cell Transplant Complications, sponsored by Weill Medical College of Cornell University.
NCT04937400 is a study of Delirium and Stem Cell Transplant Complications that is active but no longer recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 1,040 participants, above the 871-participant average among 62 other Delirium trials with a reported enrollment target (19% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04937400, a study of Delirium and Stem Cell Transplant Complications, is active but no longer recruiting, sponsored by Weill Medical College of Cornell University.
- ACTIVE NOT RECRUITING
- Registry status
- 1,040 participants
- Enrollment target
- 6
- Study locations
Study Summary
Children undergoing stem cell transplants are at risk for delirium, a temporary change in thinking and behavior. This study will define delirium rates, risk factors, and outcomes. Our eventual goal is to reduce delirium in this population.
Primary Outcome
Number of patients who develop delirium during the course of their transplant hospitalization
Conditions Studied
Interventions
- OTHER Daily screening for delirium
Study Locations (6)
California
- University of California San Francisco - San Francisco
Massachusetts
- Dana Farber Cancer Center - Boston
New York
- Weill Cornell Medical College - New York
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Tennessee
- St Jude Children's Research Hospital - Memphis
Ontario
- Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,040 participants |
| Start Date | 2021-07-12 |
| Est. Completion | 2026-07-31 |
What the registry record for NCT04937400 still lists
NCT04937400 is an observational study that tracks outcomes without assigning an intervention. Its 1,040 participants enrollment target places it among the larger protocols in the corpus, above the 871-participant average among 62 other Delirium trials with a reported enrollment target (19% higher).
The record links to 2 conditions, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which Daily screening for delirium is the first listed.
NCT04937400 lists 6 locations in 6 states (California, Massachusetts, New York).
Frequently Asked Questions
What is clinical trial NCT04937400 about?
NCT04937400 is a clinical study titled "Delirium in Children Undergoing Stem Cell Transplantation". Children undergoing stem cell transplants are at risk for delirium, a temporary change in thinking and behavior. This study will define delirium rates, risk factors, and outcomes. Our eventual goal is to reduce delirium in this population.
What is the current status of trial NCT04937400?
This trial is currently active not recruiting. The enrollment target is 1,040 participants. The study started on 2021-07-12. Estimated completion is 2026-07-31.
What conditions does trial NCT04937400 study?
This clinical trial studies the following conditions: Delirium, Stem Cell Transplant Complications.
What interventions are being tested in trial NCT04937400?
The interventions under investigation include: Daily screening for delirium (OTHER).
Who is sponsoring clinical trial NCT04937400?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04937400 being conducted?
This trial has 6 study locations across California, Massachusetts, New York, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04937400's enrollment target sits among peer trials
1,040 7th of 62 higher than 56 of 62 other Delirium trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
RECRUITING · NA
-
VoiceLove Digital Therapy for Delirium in the ICU
RECRUITING · NA
-
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
RECRUITING · NA
-
TaVNS for Delirium
RECRUITING · NA
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05219110 · 1,040 participants · NA
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- NCT06564948 · 1,040 participants · NA
Treatment for Individuals Interacting with the Criminal Justice System
- NCT06661720 · 1,040 participants · Phase 3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- NCT04685616 · 1,042 participants · Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI